Cytiva Completes Doubling of Utah Site’s Liquid Media Production Capacity

In a wide-ranging interview, Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid media production capacity in Logan, UT, Cytiva’s approach to artificial intelligence, the FDA’s Advanced Manufacturing Technology (AMT) designation granted for Cytiva’s Elevecta™ transient cell line for adeno-associated virus (AAV) manufacturing, an…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks